Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | KIF11 | P52732 | 5/20 | 0.42 |
| ▸ | FEN1 | P39748 | 3/20 | 0.35 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.35 |
| ▸ | ERCC4 | Q92889 | 1/20 | 0.35 |
| ▸ | CMA1 | P23946 | 1/20 | 0.35 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9257797 | 0.88 | CA12 (0.58) | CA9CA12KIF11DDR1MAPT | |
| SCHEMBL9259395 | 0.82 | CA12 (0.41) | CA9CA12FEN1ERCC1ERCC4 | |
| SCHEMBL9252371 | 0.81 | FEN1 (0.44) | FEN1CMA1 | |
| SCHEMBL9257826 | 0.81 | FEN1 (0.55) | CA9CA12FEN1 | |
| SCHEMBL9258552 | 0.79 | KDM4E (0.47) | CA9CA12MAPT | |
| SCHEMBL9262316 | 0.79 | KIF11 (0.42) | CA9KIF11FEN1ERCC1ERCC4 | |
| SCHEMBL9261018 | 0.78 | ALK (0.39) | DDR1 | |
| SCHEMBL9255519 | 0.78 | CCNB2 (0.36) | CA9CA12FEN1ERCC1ERCC4 | |
| SCHEMBL9264418 | 0.78 | FEN1 (0.58) | FEN1ERCC1ERCC4 | |
| SCHEMBL9257755 | 0.77 | ADORA3 (0.54) | CA9CA12FEN1ERCC1ERCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995019346-A1 | QUINAZOLINE-2,4-DIONES | SANDOZ LTD. (CH) | 1995-07-20 | — | — | WO | claimed |
| WO-1995019346-A1 | QUINAZOLINE-2,4-DIONES | SANDOZ LTD. (CH) | 1995-07-20 | — | — | WO | disclosed |